Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628)
- 1 March 1995
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 21 (3) , 175-179
- https://doi.org/10.1016/0732-8893(95)00021-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeaeDiagnostic Microbiology and Infectious Disease, 1994
- Antibacterial activity of PD 131628 and proposed disc diffusion susceptibility test criteriaJournal of Antimicrobial Chemotherapy, 1994
- Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various national committee for clinical laboratory standards susceptibility test methodsDiagnostic Microbiology and Infectious Disease, 1994
- Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parametersJournal of Clinical Microbiology, 1993
- Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinJournal of Clinical Microbiology, 1992
- In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolonesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116Antimicrobial Agents and Chemotherapy, 1992
- Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628Diagnostic Microbiology and Infectious Disease, 1991
- In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agentAntimicrobial Agents and Chemotherapy, 1991
- Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative studyJournal of Clinical Microbiology, 1981